Market Moves
Precision Neuroscience hires two Nevro veterans for its commercial push
Precision Neuroscience has named Nevro founder Konstantinos Alataris as president and Katherine Neuenfeldt, who led the US launch of Nevro's spinal cord stimulator and its insurance coverage work, as senior vice president of commercial strategies. The appointments, announced on 15 October 2026, follow a $250 million Series D. Neuenfeldt is the third executive hired to lead commercial work at Precision since 2024, after Jayme Strauss and John Woock.